Eve Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: women's-health compounded GLP-1 with monthly or longer, cheaper plans
Eve scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on Eve’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Eve is a women's-health-focused GLP-1 telehealth platform offering compounded semaglutide and tirzepatide as weekly injections, each mixed with vitamin B12 or glycine. Month-to-month plans cost $269/month for semaglutide and $400/month for tirzepatide, and 3-, 6- and 12-month plans lower the monthly rate to as little as $175 and $275. You're charged only once a provider prescribes. It's LegitScript Certified, names its pharmacy and physician group in its terms, and posts the FDA's compounding disclaimer.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Eve
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Eve at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $269/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Eve
Each dimension is scored algorithmically from Eve’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
5.7/10At $269/mo, Eve runs about 50% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.3/10Eve offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.6/10Online intake and platform experience (consult included in the price); 6 platform features disclosed.
Trust & Safety15%
7.5/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.7/10Eve's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.1/10Eve provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Eve review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $269–$400/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript certified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Eve
We walked Eve’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Answer health questions and choose semaglutide or tirzepatide.
- 2Pick a monthly, 3-, 6- or 12-month plan and add a payment method.
- 3A licensed physician reviews your intake.
- 4If prescribed, you're charged and medication ships with free 2-day shipping.
- The intake asks whether you prefer semaglutide or tirzepatide; no brand-name option is offered.
- Plan prices appear at checkout after the health questions: monthly, or 3-, 6- and 12-month billing.
- You're charged once prescribed, and not charged if a provider decides treatment isn't right for you.
- Free 2-day shipping, physician review, ongoing care and a home injection kit are listed as included.
- A 'Satisfaction Guarantee' / money-back claim is stated without detailed terms.
GLP-1 medications Eve offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Billed monthly; weekly injections with vitamin B12 or glycine. Longer plans: 3-month $225/mo ($675 every 3 months), 6-month $200/mo ($1,200 every 6 months), 12-month $175/mo (billed annually).
Billed monthly; weekly injections with vitamin B12 or glycine. Longer plans: 3-month $350/mo ($1,050 every 3 months), 6-month $325/mo ($1,950 every 6 months), 12-month $275/mo (billed annually).
Ready to get started?
Plans and promotions change often, so check Eve's current pricing and active discounts before you decide.
What we like
- Women's-health focus fills a gap left by gender-neutral GLP-1 competitors
- Compounded semaglutide and tirzepatide on one account, month-to-month or on cheaper 3-, 6- and 12-month plans
- LegitScript Certified with a verifiable ID
- Publishes the FDA compounded-medication disclaimer
- '$0 unless approved': you're charged only once a provider prescribes
- Satisfaction guarantee / money-back offer, free shipping on all orders, and FSA/HSA eligible
- Terms name its dispensing pharmacy (GoGo Meds, Ohio) and physician group (Beluga Health)
Watch-outs
- Full states-served list not disclosed publicly
- Its named pharmacy says it can't dispense sterile compounds in 10 states, including CA, TX, NJ and NC
- Month-to-month pricing ($269 sema / $400 tirz) is high; the lower rates need a 3- to 12-month plan
- Brand-name Ozempic, Wegovy and Mounjaro appear on the homepage, but no brand price or brand signup option is offered
- Disputes go to binding arbitration in New York under Delaware law
- Refund terms behind the money-back guarantee aren't detailed
Eve: a GLP-1 platform built specifically around women
Most GLP-1 telehealth services are gender-neutral by default: the same intake, the same marketing, the same everything for men and women alike. Eve (which operates as TryEve under the tagline "Empowering Women's Health") is one of the few that openly builds its positioning around women, leaning on "personalized GLP-1 treatments, transparency, and confidence-building outcomes." If you've felt like an afterthought on a generic weight-loss platform, that framing is the reason to consider Eve. The practical draw is a clear choice between the two main compounded GLP-1s, with prices you can see before you pay anything.
How the pricing works
Eve sells two medications, compounded semaglutide and compounded tirzepatide, and prices each by how long you commit. Month to month, semaglutide is $269 a month and tirzepatide is $400. Those are high numbers against a category median of $179. The discounts come from paying for a longer term: semaglutide drops to $225 a month on a 3-month plan, $200 on a 6-month plan and $175 on a 12-month plan, and tirzepatide drops to $350, $325 and $275. Longer plans are billed per term, every 3 or 6 months or once a year, so the low rates need cash up front.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
Each price covers the medication, the physician review, ongoing care, a home injection kit and free 2-day shipping. Eve's homepage also shows stock badges for brand-name Ozempic, Wegovy and Mounjaro, but it publishes no brand-name price and its signup flow only asks whether you want semaglutide or tirzepatide. If you want a brand-name pen, especially with insurance, a pharmacy or an insurance-based provider is the clearer route.
Eve also uses a pay-nothing-unless-approved model. Your card is charged once you're prescribed, and not at all if a provider decides treatment isn't right for you. Plans renew automatically and can be canceled or changed in the patient portal, and Eve says they're FSA/HSA eligible. There's also a satisfaction guarantee with a money-back promise, though its detailed terms aren't published. An intro first-month offer has appeared on Eve's promotional links, but treat any promo as something to confirm at checkout rather than count on.
Medications and how they're dispensed
Eve keeps its weight-loss menu short:
- Compounded semaglutide, a weekly injection mixed with vitamin B12 or glycine
- Compounded tirzepatide, a weekly injection mixed with vitamin B12 or glycine
- No oral option and no brand-name medication in the signup flow
The additive is chosen "based on your side effects," according to the product description. Eve's terms name the dispensing pharmacy as GoGo Meds, an Ohio pharmacy licensed in 44 states, which says it cannot dispense sterile compounds in California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia or Delaware. If you live in one of those states, ask how your prescription would be filled before you pay. To its credit, Eve publishes the FDA's standard disclaimer in plain sight: "The FDA does not review or approve any compounded medications for safety or effectiveness." Every compounding provider should show that disclaimer, and many don't.
Where Eve is strong, and where it stays vague
Eve's strengths are the women's-health focus, prices you can see before you pay, and a trust signal you can check. Eve is LegitScript Certified, and the public ID (42862417) in the footer of its signup pages can be confirmed directly on LegitScript's site. For a category full of claims you can't check, an ID you can look up yourself carries weight.
Its terms fill in more than the homepage does. The company is Eve Health, Inc., clinical care runs through Beluga Health, P.A., a Florida professional corporation, and Eve's safety page says it is not itself a healthcare provider and doesn't dispense medication. Disputes go to binding arbitration in New York under Delaware law. What's still missing is a public list of the states Eve serves, only a note that treatment can continue "if you relocate to a state we currently serve." Combined with the pharmacy's 10-state gap, that's the one thing to settle before you sign up.
Who should choose Eve
- Women who want a GLP-1 platform oriented around them
- Cash-pay patients who'll commit to a 6- or 12-month plan to get the lower monthly rate
- Anyone who wants to see the price at checkout and pay nothing unless prescribed
- Shoppers who value a LegitScript certification they can look up and an upfront FDA compounding disclaimer
Who should skip it
- Anyone who wants brand-name Ozempic, Wegovy, or Mounjaro, since Eve offers no brand-name price or signup path
- Month-to-month shoppers, since $269 for semaglutide and $400 for tirzepatide sit well above the category median
- Anyone who wants an oral GLP-1 instead of a weekly injection; Care Clinics, for one, sells oral tirzepatide
- Residents of the 10 states where Eve's named pharmacy can't dispense sterile compounds, until they confirm how the prescription is filled
Trust and medical oversight
On the positive side: a checkable LegitScript ID, a named pharmacy and physician group in its terms, the pay-nothing-until-prescribed gate, a money-back guarantee, and a clearly posted FDA compounding disclaimer are all trust signals. There are no FDA warning letters on file for Eve. The gaps are about transparency, not red flags: no public states list, and no detail on the guarantee's refund terms. You can read more about how we weigh these factors in our scoring methodology.
Bottom line
Eve is a differentiated option: women's-health positioning, compounded semaglutide and tirzepatide with the price shown before you pay, and a LegitScript ID you can look up yourself. Month to month it's expensive at $269 and $400, but a 12-month plan brings that down to $175 and $275 a month if you can pay for the term. Go in with one homework item: confirm your state is served and ask which pharmacy fills your prescription before you commit.
The Bottom Line
Eve scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Eve?
From $269/mo. See current pricing and start your free consultation.
Eve might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Eve vs…
Eve scores7.0/10
Side-by-side pricing, medications and scores. Pick a matchup.
Eve vs Amazon One Medical
Amazon One Medical scores 8.5/10

Eve vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Eve review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Eve's current pricing
Plans from $269/mo. Start your free consultation to check eligibility and today's price.